Experimental cancer drugs
- 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone
- 5N-Bicalutamide
- 6-Diazo-5-oxo-L-norleucine
- 8-Azaguanine
- Abexinostat
- Abituzumab
- ABTL0812
- Acridine carboxamide
- Actinium-225
- Adegramotide
- ADH-1
- Adozelesin
- Afimoxifene
- AI-10-49
- Alacizumab pegol
- Alkyl-lysophospholipids
- Allovectin-7
- Alvocidib
- Amatuximab
- AMG 319
- Amonafide
- Apatinib
- Artemisinin
- Ascrinvacumab
- Asunercept
- Atiprimod
- Atrasentan
- Bavituximab
- Bemcentinib
- Bempegaldesleukin
- Birabresib
- BI 811283
- BOLD-100
- Brivanib alaninate
- Bropirimine
- Brostallicin
- Bryostatin
- Buparlisib
- Cerdulatinib
- Chlorotoxin
- Cixutumumab
- Clevegen
- Clostridium novyi-NT
- Cobimetinib
- Combretastatin A-4
- CRLX101
- Cryptolepine
- Dactolisib
- Demcizumab
- Devimistat
- DHA-paclitaxel
- Dibrospidium chloride
- Dinaciclib
- Discodermolide
- Duligotuzumab
- Dz13
- Enoticumab
- Ensituximab
- Entolimod
- Entospletinib
- Epacadostat
- EPI-7386
- Erbulozole
- ERX-11
- Ethidium bromide
- Evofosfamide
- Fenretinide
- Filanesib
- Forodesine
- Fosbretabulin
- Futuximab
- Galunisertib
- Gandotinib
- Gedatolisib
- Glesatinib
- Globo H
- GVAX
- HAMLET (protein complex)
- Icrucumab
- Ieramilimab
- Imalumab
- Imetelstat
- Imexon
- IMM-101
- Indisulam
- Indolocarbazole
- Intetumumab
- Ipatasertib
- Iratumumab
- IRGD
- Irofulven
- Istiratumab
- KP1019
- Laniquidar
- Lexatumumab
- Lilotomab
- Linifanib
- Linsitinib
- Lucitanib
- Luminespib
- Mafosfamide
- Mapatumumab
- Marimastat
- Merestinib
- Mertansine
- Metapristone
- Milatuzumab
- MK-2206
- Momelotinib
- Navitoclax
- Nesvacumab
- NK012
- NL-201
- O6-Benzylguanine
- Obatoclax
- Oblimersen
- Ombrabulin
- Onapristone
- Ontuxizumab
- ONX-0801
- Oprozomib
- Oregovomab
- OSI-7904
- OX1001
- PAC-1
- Paclitaxel trevatide
- Palytoxin
- Patritumab
- Pelareorep
- Plinabulin
- Plitidepsin
- Polmacoxib
- Poziotinib
- Prexasertib
- Prinomastat
- Pritumumab
- Proxalutamide
- Quisinostat
- Quizartinib
- Radretumab
- Ralimetinib
- RAPTA
- Rebeccamycin
- RO4929097
- Robatumumab
- Ruthenium anti-cancer drugs
- Sapacitabine
- Sapanisertib
- Saracatinib
- Saridegib
- Semaxanib
- Seribantumab
- Seviteronel
- Sitravatinib
- Solitomab
- Sparsomycin
- Sulforaphane
- Swainsonine
- Talquetamab
- Tarextumab
- Tariquidar
- TAS-108
- Tasquinimod
- Tiazofurin
- Tigilanol tiglate
- Tilomisole
- Tirapazamine
- Tivantinib
- Triciribine
- Troxacitabine
- Ubenimex
- Urelumab
- Valspodar
- Vantictumab
- Vanucizumab
- Veliparib
- Vintafolide
- Vocimagene amiretrorepvec/flucytosine
- Volasertib
- Voxtalisib
- ZB716
- Zibotentan
Другие языки:
Experimental cancer drugs
Подписчиков: 0, рейтинг: 0